This is to inform you that the Board of Directors of the Company, at its meeting held on November 12, 2025, considered and approved the Unaudited Financial Results (Standalone and Consolidated) for the quarter and six months ended September 30, 2025 ( Unaudited Financial Results ). The said results were duly submitted to the stock exchanges on the same day.For ease of reference and enhanced clarity, the Unaudited Financial Results along with the Limited Review Report thereon are being made available herewith in a more legible format.

Results View source PDF Explain this filing

HCG · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.5%Reaction day

₹746.80

prior close

₹742.80

announcement price

After-mkt

timing

Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)-0.1%-1.4% vs market

Hospital peers, median of 19sector+0.3%-1.7% vs sector

On the reaction day the stock moved 1.4 pts less than Nifty Microcap 250 and 1.7 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.1

10m

+0.1

15m

-0.2

30m

-0.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.5-0.1-1.4+0.3-1.7

Next day

-1.4+0.5-1.9+0.6-2.0

-1.6-0.3-1.3-0.3-1.3

+0.2-0.5+0.7+0.0+0.2

-0.5-0.8+0.3+0.0-0.5

-3.1-2.3-0.7-0.6-2.5

-2.9-2.8-0.1-0.5-2.4

15d

-3.6-4.9+1.3-1.9-1.7

-3.6-4.7+1.1-2.7-0.9

-13.0-7.7-5.2-6.4-6.5

-21.8-7.8-13.9-7.8-14.0

UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 19Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The Board of Directors approved the Unaudited Financial Results (Standalone and Consolidated) for the quarter and six months ended September 30, 2025 at its meeting on November 12, 2025. These results were originally submitted to the stock exchanges on the same day. The current filing is a re-submission of the same results along with the Limited Review Report, presented in a clearer, more readable format for investors.

Likely market impact

This is an administrative re-filing and does not contain any new financial information or change in reported numbers. Investors should refer to the originally submitted results dated November 12, 2025 for the actual Q2/H1 FY26 performance metrics.